Vanta Clinical Research Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
- Paid Up Capital ₹ 3.00 Cr
- Company Age 6 Year, 5 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 41.10 Cr
- Satisfied Charges ₹ 17.00 Cr
- Revenue Growth -99.56%
- Profit Growth -1261.53%
- Ebitda 53.06%
- Net Worth -0.57%
- Total Assets -17.82%
About Vanta Clinical Research
Vanta Clinical Research Limited (VCRL) is a Public Limited Indian Non-Government Company incorporated in India on 12 September 2018 (Six years and five months 11 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 3.00 Cr.
The company currently has active open charges totaling ₹41.10 Cr. The company has closed loans amounting to ₹17.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Mulakala Kiran, Dopesh Mulakala, and Chintapatla Shravan serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U73100TG2018PLC126673
- Company No.
126673
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
12 Sep 2018
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Vanta Clinical Research?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chintapatla Shravan  | Director | 18-Aug-2020 | Current |
| Dopesh Mulakala | Director | 12-Sep-2018 | Current |
| Mulakala Kiran | Director | 07-Mar-2020 | Current |
Financial Performance of Vanta Clinical Research.
Vanta Clinical Research Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 99.56% decrease. The company also saw a substantial fall in profitability, with a 1261.53% decrease in profit. The company's net worth dipped by a decrease of 0.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vanta Clinical Research?
In 2021, Vanta Clinical Research had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shree Cosmetics LimitedMulakala Kiran and Dopesh Mulakala are mutual person
Sarvotham Care LimitedDopesh Mulakala is a mutual person
Vanta Bioscience LimitedDopesh Mulakala is a mutual person
Sarvotham Remedies LimitedMulakala Kiran, Dopesh Mulakala and 1 more are mutual person
Cebis India LimitedMulakala Kiran, Dopesh Mulakala and 1 more are mutual person
- Sarvotham Hexis Llp
Dopesh Mulakala is a mutual person
Charges (Loans)
₹41.10 Cr
₹17.00 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 21.13 Cr
- Others : 19.97 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jun 2022 | Others | ₹19.97 Cr | Open |
| 01 Jul 2020 | State Bank Of India | ₹21.13 Cr | Open |
| 03 Dec 2019 | Axis Bank Limited | ₹17.00 Cr | Satisfied |
How Many Employees Work at Vanta Clinical Research?
Unlock and access historical data on people associated with Vanta Clinical Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vanta Clinical Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vanta Clinical Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
